Dallan Murray insider trades
Open-market stock purchases and sales by Dallan Murray, Chief Customer Officer at Sarepta Therapeutics, Inc, from SEC Form 4 filings since May 2, 2024.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- SRPT Sarepta Therapeutics, Inc: 1 sale, last Mar 10, 2025